We have negotiated access with the CJON editors to allow open access to this publication for 1 year.

Below is a list of references with links to the CJON Supplement

Kurtin, S.E. (2012) Myelodysplastic Syndromes: The Challenge of Developing Clinical Guidelines and Supportive Care Strategies for a Rare Disease. Clin J Oncol Nurs, 16 (suppl 1), 5-7. DOI: 10.1118/12.CJON.S1.5-7

Ridgeway, J., Fetcher, L., Murray, C., & Borras, N. (2012) Update on the Science of Myelodysplastic Syndromes. Clin J Oncol Nurs, 16 (suppl 1), 9-22. DOI:10.1188/12.CJON.S1.9-22

Kurtin, S.E., Demakos, E.P., Hayden, J., & Boglione, C. (2012) Treatment of Myelodysplastic Syndromes: Practical Tools for Effective Management. Clin J Oncol Nurs, 16 (suppl 1), 23-35. DOI: 10.1188/12.CJON.S1.23-35

Shah, J., Kurtin, S.E., Arnold, L., Lindroos-Kolqvist, P., & Tinsley, S. (2012) Management of Transfusion-Related Iron Overload in Patients with Myelodysplastic Syndromes. Clin J Oncol Nurs, 16 (suppl 1), 37-46. DOI: 10.1188/12.CJON.S1.37-46.

Thomas, M.L, Crisp, N., & Campbell, K. (2012) The Importance of Quality of Life for Patients Living With Myelodysplastic Syndromes. Clin J Oncol Nurs, 16 (suppl 1), 47-57. DOI:10.1188/12.CJON.S1.47-57

Kurtin, S.E., Paterson, P., Wintrich, S., Iraca, T., Hassan, A.A., Murray, D. & Hogan, S. (2012) Patient and Family Resources for Living With Myelodysplastic Syndromes. Clin J Oncol Nurs, 16 (suppl 1), 58-64 DOI:10.1188/12.CJON.S1.58-64

Additional Resources:

Transfusion Tracker

Lenalidomide Blueprint Order Form

Disease Snapshot – page 31 Kurtin et al

Overview or resources with web-links – pages 59-60 Kurtin et al.

Commonly asked questions – page 63-64 Kurtin et. al.